Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Fulgent Genetics, |
RCV005006542 | SCV005637677 | uncertain significance | Retinitis pigmentosa 51; Bardet-Biedl syndrome 8 | 2024-02-27 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV004746906 | SCV005366001 | uncertain significance | TTC8-related disorder | 2024-01-03 | no assertion criteria provided | clinical testing | The TTC8 c.1309C>G variant is predicted to result in the amino acid substitution p.Leu437Val. To our knowledge, this variant has not been reported in the literature. This variant is reported in 0.0039% of alleles in individuals of European (Non-Finnish) descent in gnomAD. At this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. |